NCT03169491 is a NA clinical trial of Continuous positive airway pressure (CPAP) in Sleep Apnea, Obstructive, sponsored by Instituto Nacional de Enfermedades Respiratorias.

Who is sponsoring NCT03169491?

NCT03169491 is sponsored by Instituto Nacional de Enfermedades Respiratorias.

What drugs are being tested in NCT03169491?

Interventions in NCT03169491: Continuous positive airway pressure (CPAP).

What condition does NCT03169491 study?

NCT03169491 studies Sleep Apnea, Obstructive, Child, Continuous Positive Airway Pressure, Adenoidectomy, Tonsillectomy.

Is NCT03169491 still recruiting?

NCT03169491 is currently status unknown. Last updated 12 March 2019.

Last reviewed 2019-03-12 · How we verify

NCT03169491

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of CPAP and Adenotonsillectomy in Upper Airway Volume of Children With OSAS

Status unknown NA Last updated 12 March 2019

What this trial tests

NA trial testing Continuous positive airway pressure (CPAP) in Sleep Apnea, Obstructive in 150 participants. Status unknown.

Timeline

4 July 2016

Primary endpoint
30 August 2019

30 November 2019

Quick facts

Lead sponsor	Instituto Nacional de Enfermedades Respiratorias
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	150
Start date	4 July 2016
Primary completion	30 August 2019
Estimated completion	30 November 2019
Sites	1 location across Mexico

Drugs / interventions tested

Continuous positive airway pressure (CPAP)

Conditions studied

Sleep Apnea, Obstructive — all drugs for Sleep Apnea, Obstructive →
Child — all drugs for Child →
Continuous Positive Airway Pressure — all drugs for Continuous Positive Airway Pressure →
Adenoidectomy — all drugs for Adenoidectomy →

Sponsor

Instituto Nacional de Enfermedades Respiratorias — full company profile →

Who can join

Adults 4 to 14, any sex, with Sleep Apnea, Obstructive or Child. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Obstructive sleep apnea syndrome (OSAS) in children has high prevalence and severe complications, and its first line of treatment (adenotonsillectomy) has risk of complications. Even though the use of presurgical CPAP seems logical due to its effects in adults, it must be studied in children due to the different physiopathology and adherence. One non-invasive way of study the effect is via acoustic pharyngometry, which can measure the anatomical site of obstruction. The post-surgical anatomical changes could correlate with a persistent OSAS, which would be helpful in selecting those patients who require a post surgical sleep study. The main goal of the study is to cuantify the changes in the oropharyngeal volume via acoustic pahryngometry after CPAP use, and also the changes after adentonsillectomy in children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Continuous positive airway pressure (CPAP)

Trials testing the same drug.

NCT06915831 — Type 1 Diabetes and Obstructive Sleep Apnea · NA · recruiting
NCT07062770 — Assessment of Circuit Rebreathing During CPAP Therapy · NA · recruiting
NCT06029959 — Stroke and CPAP Outcome Study 3 · NA · completed
NCT05393531 — First Line Obstructive Sleep Apnea Treatment Study · Phase 4 · completed
NCT06277115 — Acute and Long-term Effects of CPAP in OSA · NA · completed

Other recruiting trials for Sleep Apnea, Obstructive

Currently open trials in the same condition.

NCT06828835 — The REPOSE (Reach for Equity in Pediatric Sleep Evaluation) Navigation Intervention · NA · recruiting
NCT06915831 — Type 1 Diabetes and Obstructive Sleep Apnea · NA · recruiting
NCT07176767 — The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents · recruiting
NCT06573372 — Evaluating the Diagnostic Efficacy of Smartwatch and Smartphone for Sleep Apnea · recruiting
NCT06848647 — Treatment of Sleep Apnea to Improve Metabolic Health · recruiting

Other Instituto Nacional de Enfermedades Respiratorias trials

Trials by the same sponsor.

NCT06471101 — Applying Artificial Intelligence to Identify Subphenotypes of Acute Kidney Injury in Mexican Patients With Severe COVID- · completed
NCT06691321 — Caspofungin for Pneumocystis Pneumonia in PLWHIV. · recruiting
NCT04443673 — Glycine Supplement for Severe COVID-19 · NA · terminated
NCT04517630 — Renal Biomarkers in AKI and COVID-19 · completed
NCT06444893 — Morphofunctional, Gene, Inflammation Molecules and Oxidative Stress Analysis in Kidney Tissue of COVID-19 Patients · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03169491 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto Nacional de Enfermedades Respiratorias
Last refreshed: 12 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03169491.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing